PreSENTIA NIPD Genetics hereditary cancer Logo (WIPO, 12/23/2019)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark PreSENTIA NIPD Genetics hereditary cancer was filed as Figurative mark on 12/23/2019 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Series of letters presenting different forms of writing #Series of letters in different dimensions #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1517222 |
| Register number | 018083687 |
| Countries | 
|
| Base trademark |
No. 018083687,
November 9, 2019
|
| Application date | December 23, 2019 |
| Expiration date | December 23, 2029 |
Trademark owner
31, Neas Engomis, Engomi
2409 Nicosia
CY
2409 Nicosia
CY
Trademark representatives
2-4, Arch. Makaros III Avenue,
Capital Center, 7th floor
CY
goods and services
01
Kits and reagents for genetic testing for medical and
scientific research purposes in the field of cancer
detection; kits and reagents for cancer testing for medical
and scientific research purposes; nucleic acid based kits
and reagents for testing cancer diseases for medical and
scientific research purposes
42
Medical laboratory services for testing of cancer and cancer
prevention; design and development of medical diagnostic
tests and products; medical and scientific research in the
field of genetic testing; providing medical and scientific
research information in the field of genetic testing;
genetic testing for scientific research and analysis
purposes in the field of cancer detection; genetic
engineering services; scientific, laboratory, clinical,
medical, and technological research and analysis services in
the fields of nucleic acid analysis, cancer testing, and
genetics; scientific research for medical purposes in the
area of cancerous diseases
44
Medical analysis services for the diagnosis and prognosis of
cancer; medical genetic testing services for diagnosis,
prevention and treatment of cancer; medical testing of blood
for diagnosis of cancer; genetic testing and genetic
counseling in the field of cancer detection; medical and
health services relating to DNA and genetics testing; RNA or
DNA analysis for cancer diagnosis and prognosis
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 24, 2021 | 2021/8 Gaz | UA | Rejection |
| January 15, 2021 | 2021/5 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 23, 2020 | 2020/53 Gaz | TR | Rejection |
| November 16, 2020 | 2020/47 Gaz | IN | Rejection |
| October 1, 2020 | 2020/42 Gaz | IL | Rejection |
| September 18, 2020 | 2020/39 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 1, 2020 | 2020/36 Gaz | RS | Rejection |
| July 30, 2020 | 2020/32 Gaz | RU | Rejection |
| April 8, 2020 | 2020/15 Gaz | US | Rejection |
| December 23, 2019 | 2020/7 Gaz | EM | Registration |
ID: 141517222